Genovese Burford & Brothers Wealth & Retirement Plan Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-969
Closed -$83K 239
2018
Q2
$83K Buy
969
+2
+0.2% +$164 0.03% 127
2018
Q1
$75K Buy
+967
New +$77.8K 0.03% 137
2017
Q4
Sell
-741
Closed -$63K 363
2017
Q3
$63K Hold
741
0.03% 132
2017
Q2
$60K Hold
741
0.02% 131
2017
Q1
$63K Sell
741
-150
-17% -$12K 0.03% 127
2016
Q4
$66K Buy
891
+150
+20% +$11.2K 0.02% 146
2016
Q3
$59K Hold
741
0.02% 144
2016
Q2
$58K Hold
741
0.02% 134
2016
Q1
$53K Hold
741
0.03% 130
2015
Q4
$62K Buy
+741
New +$61.5K 0.03% 113

Other funds holding LLY

Genovese Burford & Brothers Wealth & Retirement Plan Management's LLY Position: Q3 2018 in Review

Genovese Burford & Brothers Wealth & Retirement Plan Management sold out of Eli Lilly (LLY) in Q3 2018, closing a stake of 969 shares — an estimated $83K sold.

Genovese Burford & Brothers Wealth & Retirement Plan Management first reported a position in LLY in Q4 2015 and held it in 10 quarters. The position peaked at $83K in Q2 2018. 1,432 funds tracked by Wall St. Rank hold LLY as of Q3 2018.

  • Genovese Burford & Brothers Wealth & Retirement Plan Management reported no remaining Eli Lilly position as of Q3 2018 after selling out during the quarter.
  • Genovese Burford & Brothers Wealth & Retirement Plan Management sold 969 Eli Lilly shares in Q3 2018, an estimated $83K.
  • Genovese Burford & Brothers Wealth & Retirement Plan Management first reported a position in Eli Lilly in Q4 2015 and held it in 10 quarters.
  • Genovese Burford & Brothers Wealth & Retirement Plan Management's Eli Lilly position peaked at $83K in Q2 2018.
  • 1,432 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2018.

Based on Genovese Burford & Brothers Wealth & Retirement Plan Management's 13F filing for Q3 2018, filed 13 Nov 2018.